Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion

Chunmei Yang,Guanya Guo,Bo Li,Linhua Zheng,Ruiqing Sun,Xiufang Wang,Juan Deng,Gui Jia,Xia Zhou,Lina Cui,Changcun Guo,Xinmin Zhou,Patrick S. C. Leung,M. Eric Gershwin,Yulong Shang,Ying Han

Hepatology international（2022）

引用 8|浏览19

暂无评分

摘要

Current treatment guidelines recommend ursodeoxycholic acid (UDCA) as the first-line treatment for new-diagnosed primary biliary cholangitis (PBC) patients. However, up to 40

查看译文

关键词

Adverse outcome,Autoimmune liver disease,Biochemical response,Complication,Early prediction,Primary biliary cholangitis,Prognosis,Retrospective cohort study,Stratified therapy,Therapeutics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要